INTRODUCTION {#sec1-1}
============

Ageing is multi-factorial which reflects at cellular, organ and organism levels. Through advancements in modern medicine and technology more humans are surviving into later life with the potential to reach their technical life span of approximately 120 years of age.\[[@ref1]\] However, part of the disability currently seen\[[@ref2]\] in the elderly is due to lifestyle-induced diseases (for example, smoking related to heart disease and stroke). The elderly have a distinct spectrum of diseases which includes stroke, hypertension, coronary heart diseases, parkinsonism, osteoporosis, osteoarthritis, constipation, urinary incontinence, insomnia, vertigo, deafness and dementia including Alzheimer\'s disease (AD).

Until recently, cognitive decline was considered characteristic of normal ageing. In the past decade, the surveillance studies have noted that 15% of those over the age of 65 have moderate to severe dementia. AD once considered to be rare, is now recognized as the most common disorder of dementia.\[[@ref3][@ref4]\]

Dementia is a chronic disorder in which there is progressive decline in intellect, behavior and personality.\[[@ref5]\] Certain conditions such as AD, multi infarct dementia, uremia, chronic hepatic encephalopathy, thyroid/adrenal dysfunction, pernicious anemia, pellagra, brain tumors, subdural hematoma and head injury may cause dementia. Among these conditions, AD is being projected as one of the important memory disorder which calls for proper management.

The classic triad of senile plaques, neurofibrillary tangles and granulovascular degeneration are suggested to be pathogenic of AD. Clinical features include memory loss, difficulty in learning and retaining new information, depressive symptoms, aggression, agitation and disorders of perception.

With Parkinson\'s disease serving as the model for neurotransmitter replacement therapy, great expectations arose for analogous treatment success for victims of AD. Unfortunately, the results of replacement therapy have been notably disappointing.\[[@ref6]\]

Keeping the above in view, a careful review has been done about the herbal recipes suggested by *Ayurvedic* classics in the management of disease called *Vātavyādhi* (nervous system disorders).

In addition to the above diseased condition an analysis has also been carried out about the memory enhancing drugs categorized under *Medhya Rasāyana* (memory rejuvenators) group of drugs.

AD-AN *AYURVEDIC* VIEW {#sec1-2}
======================

There is no condition as described in Ayurveda which can be clinically equated to AD. But in *Ayurvedic* classics *Smṛtināsha* (loss of memory) is mentioned among the prodromal symptom of *jarā* (ageing).\[[@ref7]\] In *Jarāvasthā* (old age), which starts from 60 years of age as per *Caraka*, *Smṛti* and other mental faculties gradually deteriorate naturally. As per *Vāgbhaṭa* (As.Sam.Sha 8/25) and Sharṅgadhara (Prathama Khaṇḍa 6/20), the functions of mind and Buddhi decline start declining from the 9^th^ decade of life. Mental function declines at 11^th^ decade of life as per Sharṅgadhara. Further, *Smṛtibhramsha* (disturbed memory) is described as a symptom where *Smṛti* (memory) is vitiated by *rajas* (passion) and *tamas* (obscurity).\[[@ref8]\] Thus, senile dementia can be interpreted as *Jarājanya Smṛtibhramsha* according to *Ayurvedic* principles.\[[@ref9]\] Ayurveda suggests *Nasya karma* (nasal administration) for all the *Jatrugataroga* (diseases of head and neck) which may have beneficial therapeutic effect in the patients of AD. Some of the important memory enhancing herbs mentioned in the ancient *Ayurvedic* literature is enumerated in [Table 1](#T1){ref-type="table"}.\[[@ref10]\]

###### 

*Medhya Rasāyana* (memory enhancers)

![](ASL-34-3-g001)

Herbs indicated in the treatment of *Vātavyādhi* (nervous system disorders)\[[@ref11]\] which may help in restoration of declining memory are listed in [Table 2](#T2){ref-type="table"}.

###### 

Memory enhancer herbs
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MODERN SCIENTIFIC VALIDATIONS OF HERBAL MEMORY ENHANCERS {#sec1-3}
========================================================

Certain medicinal plants and their combinations mentioned in *Ayurvedic* material medica have been evaluated in various experimental studies for their memory enhancing property are enumerated in [Table 3](#T3){ref-type="table"}.

###### 

Herbs found useful for Alzheimer\'s disease in experimental studies

![](ASL-34-3-g003)

From the above list, the herbs which were subjected to extensive evaluation for their activity in the management of dementia are summarized below.

Brāhmī (Bacopa monieri) {#sec2-1}
-----------------------

Considerable number of studies (animal experiments and clinical trials)\[[@ref37][@ref38]\] have been done to evaluate its efficacy in learning and memory. It was concluded that *Brāhmī* has a positive effect on learning and both short-term and long-term memory. In a recent double-blind, placebo-controlled clinical trial,\[[@ref39]\] the above findings were further proved and it was found that maximal effect was evident after 12 weeks of treatment. In another double blind randomized placebo control clinical study covering 76 adults aged 40-60 years and carried out over a 3 month period, it was concluded that the drug has significant beneficial action on retention of new information.\[[@ref40]\] Saponins are considered as the active compounds.\[[@ref41]\] Ethanolic extract of aerial parts and rhizome from the plant possessed nootropic activity.\[[@ref42]\] It has been suggested that bacosides are able to induce membrane dephosphorylation with concomitant increase in protein and ribonucleic acid turnover in specific brain areas.\[[@ref43]\] Other probable actions include: (1) Cognitive enhancement through modulatory effect on the cholinergic system,\[[@ref44]\] (2) enhancement of protein kinase activity in hippocampus.\[[@ref45]\]

Maṇḍūkaparṇī (Centella asiatica) {#sec2-2}
--------------------------------

*Maṇḍūkaparṇī* is highly prized in *Ayurvedic* treatises as a *Medhya* (Memory and intellect promoting) and *vayassthāpana* (anti-ageing) drug. In *Bhāvaprakāsha* it has been stated that *Maṇḍūkaparṇī* and *Brāhmī* have very similar pharmacological activities.\[[@ref46]\] A double blind clinical trial involving 30 mentally retarded children (age, 7-8 years) who received the drug (whole plant, dried in shade) for 3 months, showed improved cognitive function.\[[@ref47]\] In recent investigations,\[[@ref42]\] it was demonstrated that the aqueous extract of the plant (200 mg/kg, 14 days) improved learning and memory, in both the shuttle box and step through paradigms in male Wister rats. The extract was also found to be effective in preventing cognitive deficits in an intracerebroventricular Streptozotocin model of AD in rats. It is believed that an antioxidant mechanism is involved. Asiatic acid, the principal triterpinoid constituent of *C. asiatica* has been demonstrated to reduce hydrogen peroxide induced cell death and lower intracellular free radical concentration.\[[@ref48]\] Asiatic acid has been patented (Hoechst Aktiengesellschaft) as a therapeutic agent for the treatment of dementia and this compound as well as some related synthetic analogues have been shown to protect cultured cortical neurons from glutamate-induced excite-toxicity.\[[@ref49]\] Aqueous extract of the plant at a dose level of 300 mg/kg decreased the pentylenetetazole-kindled seizures in rats thus, indicating antiepileptic action of the herb.\[[@ref50]\] The memory enhancing activity of *C. asiatica* may be due to Acetylcholinesterase inhibiting activity of asiatic acid and betulinic acid that can be potential lead for the symptomatic treatment of AD.\[[@ref51]\]

Haridrā (Curcuma longa) {#sec2-3}
-----------------------

In *Caraka Samhitā, Haridrā* has been classified as curative of skin diseases (*Kuṣṭhaghna*), anti-obesity and scarifying (*Lekhanīya*), antidote to poisoning (*Viśaghna*) and has been recommended for the treatment of jaundice, cough, coryza, senility and impaired vision.\[[@ref52]\] β-Amyloid induced oxidative stress appears to be an important pathway of neuronal cell death in AD. A bioassay guided fractionation of methanol (90%) extract of turmeric led to the isolation of calebin-A and the curcumins which effectively protected (*in vitro*) neuronal cells against β-Amyloid deposition.\[[@ref53]\] In another study curcumin, on oral administration to alcohol-fed rats, caused a significant reversal of brain lipid peroxidation, thus indicating a neuro-protective role.\[[@ref54]\]

DISCUSSION {#sec1-4}
==========

*Ācaryas* of Ayurveda opine that *Jarā* (senility) is a natural disease (*Svābhāvika vyādhi*). Premature senility can be well-prevented by regular intake of *Rasāyana* or *Vayassthāpana* (longevity promoter) drugs. It is suggested to introduce *Rasāyana* drugs during young and middle phases of life. *Ayurvedic* classics document the decade wise decline in individuals and emphasized further that the decline of intelligence and memory starts at the end of 40^th^ year of the life.

In different phases of life, different dośas predominate: In the early part of life, *kaphaja dośa* (those arising out of biological humor which maintains structural integrity) predominates in the body; in the middle age, *pitta* (biological humor which resembles enzymatic and endocrinal functions) related diseases predominate and *vāta* (biological humor representing nervous system functions) dominance leads to degenerative changes during old age. *Rasāyana* drugs by their specific activity subdue the vitiated *vāta* and help in preserving the bodily physiological functions by restoring the feeling of well-being. Everybody is gifted with the capacity to regenerate destroyed cells. At the end of last century the scientists proved that damaged nerve cells can be regenerated contrary to the findings of earlier research studies. *Caraka* has identified *Rāsnā (Pluchea lanceolata*) as the prime drug for subduing *vāta* vitiation. *Vāgbhaṭa* has identified *Lasuna (Allium sativum*) as one of the prime drugs to curtail the pathological changes due to *vāta dośa*. It is also suggested that intake of *Harītakī* (*Terminalia chebula*) with different *anupānas* (vehicles) in different seasons not only helps to prevent seasonal diseases but also helps in regeneration of diseased cells. The combination of three fruits, i.e. *Triphala* (Three myrobalans) is suggested as one of the important *Rasāyana* group. Among *Triphalā*, *Caraka* identifies *Āmalaki* (*Emblica officinalis*) to be the best fruit bestowed with *Vayassthāpana* activity (youth retaining activity). Both *harītakī* and *āmalakī* are attributed with *Medhya* property. *Brāhmī* and *Maṇḍūkaparṇī* share similar pharmacological properties. *Caraka* enumerates *Maṇḍūkaparṇī* among *Medhya Rasāyanas* while *Vāgbhaṭa* considers *Brāhmī* as a prime drug from *apasmāra* which is characterized by loss of *Smṛti* (memory) and *saṃjñā* (consciousness). *Vāgbhaṭa* also considers *lasuna* as the prime drug to treat *vātavyādhi*. During old age, body enters the phase of *vāta* dominance and *vata* decreases the *asthi dhātu* and the related *majjā dhātu* too. Brain tissue is referred as *mastuluṅga majjā* which goes into the degenerative phase due to interplay of excessive vata. In such conditions *Lasūna* in *kalka* dosage form as suggested by Sage *Kaśyapa* and *Śodhala* help to prevent degenerative changes in the brain. In a controlled clinical trial with *Vayassthāpana* group (8 out of 10 herbs suggested by *Caraka*) it was observed the volunteers who received *vayassthāpana* compound have shown improvement in the symptoms like anxiety and loss of concentration.\[[@ref55]\]

CONCLUSION {#sec1-5}
==========

Dementia pathologies such as AD are reaching epidemic proportions. They are not being successfully managed effectively by symptomatic treatments.\[[@ref56]\] Currently, two centrally acting, reversible anti-cholinesterase drugs, tacrine and donepezil, are used to increase acetylcholine levels in the brain. Beneficial effects of the drugs are most notable in the early stages of the disease and lessen as the disease progresses.\[[@ref57]\] There are many herbs from ethno-medicinal source which have been studied for their experimental potential in treating AD. A judicious combination of *Ayurvedic* methodology along with proved herbs from varied origin can be used in a in the management of AD.
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